全文获取类型
收费全文 | 179239篇 |
免费 | 35265篇 |
国内免费 | 4776篇 |
专业分类
耳鼻咽喉 | 5380篇 |
儿科学 | 5590篇 |
妇产科学 | 2690篇 |
基础医学 | 6638篇 |
口腔科学 | 1959篇 |
临床医学 | 31128篇 |
内科学 | 51286篇 |
皮肤病学 | 7629篇 |
神经病学 | 16265篇 |
特种医学 | 7353篇 |
外国民族医学 | 21篇 |
外科学 | 43513篇 |
综合类 | 5756篇 |
现状与发展 | 78篇 |
一般理论 | 2篇 |
预防医学 | 8679篇 |
眼科学 | 4516篇 |
药学 | 4464篇 |
29篇 | |
中国医学 | 1934篇 |
肿瘤学 | 14370篇 |
出版年
2024年 | 612篇 |
2023年 | 5260篇 |
2022年 | 2455篇 |
2021年 | 4809篇 |
2020年 | 7341篇 |
2019年 | 3343篇 |
2018年 | 8438篇 |
2017年 | 8436篇 |
2016年 | 9361篇 |
2015年 | 9938篇 |
2014年 | 17259篇 |
2013年 | 17036篇 |
2012年 | 7652篇 |
2011年 | 7877篇 |
2010年 | 11782篇 |
2009年 | 15336篇 |
2008年 | 7240篇 |
2007年 | 5442篇 |
2006年 | 7975篇 |
2005年 | 5459篇 |
2004年 | 3917篇 |
2003年 | 2756篇 |
2002年 | 2779篇 |
2001年 | 4450篇 |
2000年 | 3646篇 |
1999年 | 3962篇 |
1998年 | 4159篇 |
1997年 | 3947篇 |
1996年 | 3742篇 |
1995年 | 3569篇 |
1994年 | 2237篇 |
1993年 | 1774篇 |
1992年 | 1600篇 |
1991年 | 1613篇 |
1990年 | 1245篇 |
1989年 | 1318篇 |
1988年 | 1157篇 |
1987年 | 952篇 |
1986年 | 982篇 |
1985年 | 776篇 |
1984年 | 572篇 |
1983年 | 542篇 |
1982年 | 524篇 |
1981年 | 420篇 |
1980年 | 367篇 |
1979年 | 314篇 |
1978年 | 328篇 |
1977年 | 396篇 |
1975年 | 277篇 |
1972年 | 302篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
51.
52.
目的:探讨益气通脉饮治疗气虚血瘀型冠心病心绞痛的临床疗效。方法:选取2017年10月—2019年2月烟台业达医院收治的气虚血瘀型冠心病心绞痛的患者90例作为研究对象,根据随机数字表法将所选患者均分为两组,每组各45例,两组的一般资料经统计学方法,差异无统计学意义(P>0.05),因此具有可比性。对照组给予常规西药进行治疗,观察组在对照组治疗基础上给予益气通脉饮治疗,1个月后比较两组临床的疗效,评估治疗前后中医证候、心绞痛症状分级和血脂水平。临床检测的数据通过统计产品与服务解决方案(Statistical Product and Service Solutions,SPSS) 19.0软件进行分析和处理,计量的数据使用平均数±标准差(x±s)表示,采用双侧t检验,计数的数据采用χ~2检验,以%表示,以P<0.05为差异有统计学意义。结果:治疗后,对照组和观察组都有一定疗效,但观察组的改善中医证候总有效率95.56%(43/45),高于对照组的82.22%(37/45),两组比较具有统计学意义(P<0.05);心绞痛的症状总有效率观察组为93.33%(42/45),对照组为77.78%(35/45),两组比较差异有统计学意义(P<0.05);与治疗前相比较,两组治疗后的三酰甘油(Triglyceride,TG)、血清总胆固醇(Serum Total Cholesterol,TC)、高密度脂蛋白胆固醇(High Density Liptein Cholesterol,HDL-C)水平均降低(P<0.05),且观察组治疗后低于对照组(P<0.05),两组治疗后的HDL-C升高(P<0.05),组间比较,差异无统计学意义(P>0.05)。结论:益气通脉饮治疗气虚血瘀型冠心病心绞痛的疗效显著,值得临床进一步研究与推广应用。 相似文献
53.
Breast Elastography: How to Perform and Integrate Into a “Best-Practice” Patient Treatment Algorithm
Breast elastography has been available for more than 15 years but is not widely incorporated into clinical practice. Many publications report extremely high accuracy for various breast elastographic techniques. However, results in the literature are extremely variable. This variability is most likely due to variations in technique, a relatively steep learning curve, and variability in methods between vendors. This article describes our protocol for performing breast elastography using both strain elastography and shear wave elastography, which produces high sensitivity and specificity. Additionally, we will describe the most commonly known false-positive and false-negative lesions as well as how to detect them. 相似文献
54.
The term “oligometastatic prostate cancer” refers to a heterogeneous group of disease states currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo oligometastases, and oligoprogressive disease likely have unique biologic underpinnings and natural histories. Evidence suggesting the existence of a subset of patients who harbor prostate cancer with limited metastatic potential currently includes disparate and overwhelmingly retrospective reports. Nevertheless, emerging prospective data have corroborated the “better-than-expected,” retrospectively observed outcomes, particularly in the setting of oligorecurrent prostate cancer. Improved functional imaging with prostate-specific membrane antigen-targeted strategies may enhance the identification of patients with oligometastatic prostate cancer in the short term. In the long term, refinement of the oligometastatic case definition likely will require biologic risk-stratification schemes. To determine optimal treatment strategies and identify patients most likely to benefit from metastasis-directed therapy, future efforts should focus on conducting high-quality, prospective trials with much-needed molecular correlative studies. 相似文献
55.
56.
57.
58.
59.
60.
Discoid lupus erythematosus (DLE) is the most common skin manifestation of lupus; however, the molecular mechanisms underlying DLE remain unknown. Therefore, we aimed to identify key differentially expressed genes (DEGs) in discoid lupus skin and investigate their potential pathways.To identify candidate genes involved in the occurrence and development of the disease, we downloaded the microarray datasets and GSE52471 from the Gene Expression Database (GEO). DEGs between discoid lupus skin and normal controls were selected using the GEO2R tool and Venn diagram software ( GSE72535http://bioinformatics.psb.ugent.be/webtools/Venn/). The Database for Annotation, Visualization, and Integrated Discovery (DAVID), Enrichr, and Cytoscape ClueGo were used to analyze the Kyoto Encyclopedia of Gene and Genome pathways and gene ontology. Protein-protein interactions (PPIs) of these DEGs were further assessed using the Search Tool for the Retrieval Interacting Genes version 10.0.Seventy three DEGs were co-expressed in both datasets. DEGs were predominantly upregulated in receptor signaling pathways of the immune response. In the PPI network, 69 upregulated genes were selected. Furthermore, 4 genes (CXCL10, ISG15, IFIH1, and IRF7) were found to be significantly upregulated in the RIG-I-like receptor signaling pathway, from analysis of Enrichr and Cytoscape ClueGo.The results of this study may provide new insights into the potential molecular mechanisms of DLE. However, further experimentation is required to confirm these findings. 相似文献